The criteria appears to address the relative change to the baseline state given in #29. Thus, if #29 and #31 are both well-described, #32 can be calculated from these and would then also be well-described. What would be important to note here is the shape of the dose-response curve, i.e. assumed linear or non-linear within the area of validity (#1 Scope of value factor)?
The criteria appears to address the relative change to the baseline state given in #29. Thus, if #29 and #31 are both well-described, #32 can be calculated from these and would then also be well-described. What would be important to note here is the shape of the dose-response curve, i.e. assumed linear or non-linear within the area of validity (#1 Scope of value factor)?